Literature DB >> 23430080

Eosinophils and mast cells: a comparison of nasal mucosa histology and cytology to markers in nasal discharge in patients with chronic sino-nasal diseases.

Moritz Gröger1, Andreas Bernt, Maria Wolf, Brigitte Mack, Elisabeth Pfrogner, Sven Becker, Matthias F Kramer.   

Abstract

Allergic rhinitis (AR), nasal polyps (NP) as well as chronic rhinosinusitis (CRS) are all known to be associated with eosinophilic infiltration and elevated numbers of mast cells (MC) within the mucosa. Both cell types and their markers eosinophilic cationic protein (ECP) and tryptase are utilized in the diagnosis and management of chronic sino-nasal diseases. Mucosal cytology samples were gathered by cytobrush, histological samples were obtained from the inferior turbinate. In both sample sets, the number of eosinophils and MC was determined. Their corresponding markers ECP and tryptase were quantified from nasal discharge. Patients were grouped with reference to their main diagnosis: AR (n = 34), NP (n = 25), CRS (n = 27) and controls (n = 34). Eosinophil counts from cytobrush and ECP levels were significantly elevated in NP compared to all other groups-31- and 13-fold over control, respectively. However, histologic review did not reveal any difference in eosinophil count among groups. Tryptase was significantly elevated threefold in AR versus CRS and controls. No correlation to cytological and histological MC counts could be found. ECP levels in nasal discharge as well as eosinophil counts can provide useful information with regard to the diagnosis. Likewise, tryptase concentrations can do. The presented data show that the measurement of markers in nasal discharge is superior in differentiating among diagnosis groups. Given that the collection of nasal secretions is more comfortable for patients than the more invasive techniques, we recommend first line ECP and tryptase testing performed on nasal secretions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23430080     DOI: 10.1007/s00405-013-2395-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  40 in total

1.  [Incidence and detection of fungi and eosinophilic granulocytes in chronic rhinosinusitis].

Authors:  H Braun; H Stammberger; W Buzina; K Freudenschuss; A Lackner; A Beham
Journal:  Laryngorhinootologie       Date:  2003-05       Impact factor: 1.057

2.  Neutrophils as a novel source of eosinophil cationic protein in IgE-mediated processes.

Authors:  Javier Monteseirín; Antonio Vega; Pedro Chacón; M Jesús Camacho; Rajaa El Bekay; Juan A Asturias; Alberto Martínez; Pedro Guardia; Ramón Pérez-Cano; José Conde
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

3.  Nasal polyposis: immunohistochemistry and bioelectrical findings (a hypothesis for the development of nasal polyps).

Authors:  J M Bernstein; J Gorfien; B Noble; J R Yankaskas
Journal:  J Allergy Clin Immunol       Date:  1997-02       Impact factor: 10.793

Review 4.  The human mast cell.

Authors:  M K Church; F Levi-Schaffer
Journal:  J Allergy Clin Immunol       Date:  1997-02       Impact factor: 10.793

5.  A brush method to harvest cells from the nasal mucosa for microscopic and biochemical analysis.

Authors:  U Pipkorn; G Karlsson; L Enerbäck
Journal:  J Immunol Methods       Date:  1988-08-09       Impact factor: 2.303

6.  Correlation of immunoglobulin E, eosinophil cationic protein, and eosinophil count with the severity of childhood perennial allergic rhinitis.

Authors:  Shuei Tu Chen; Hai Lun Sun; Ko Hsiu Lu; Ko Huang Lue; Ming Chih Chou
Journal:  J Microbiol Immunol Infect       Date:  2006-06       Impact factor: 4.399

7.  [Allergic rhinopathy: Magic Lite SQ Allergy Screen Inhalant and CAP-FEIA SX1--comparison of two allergen-specific screening tests in serum].

Authors:  G Rasp
Journal:  Laryngorhinootologie       Date:  1992-06       Impact factor: 1.057

8.  Allergic rhinitis to grass pollen: measurement of inflammatory mediators of mast cell and eosinophils in native nasal fluid lavage and in serum out of and during pollen season.

Authors:  G Di Lorenzo; P Mansueto; M Melluso; G Candore; A Colombo; M E Pellitteri; A Drago; M Potestio; C Caruso
Journal:  J Allergy Clin Immunol       Date:  1997-12       Impact factor: 10.793

9.  Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes.

Authors:  S Sur; D G Glitz; H Kita; S M Kujawa; E A Peterson; D A Weiler; G M Kephart; J M Wagner; T J George; G J Gleich; K M Leiferman
Journal:  J Leukoc Biol       Date:  1998-06       Impact factor: 4.962

10.  Medical management of sinusitis.

Authors:  M Kaliner
Journal:  Am J Med Sci       Date:  1998-07       Impact factor: 2.378

View more
  8 in total

1.  Sample collection for laboratory-based study of the nasal airway and sinuses: a research compendium.

Authors:  Conner J Massey; Fernando Diaz Del Valle; Waleed M Abuzeid; Joshua M Levy; Sarina Mueller; Corrina G Levine; Stephanie S Smith; Benjamin S Bleier; Vijay R Ramakrishnan
Journal:  Int Forum Allergy Rhinol       Date:  2019-12-17       Impact factor: 3.858

2.  A pilot study of symptom profiles from a polyp vs an eosinophilic-based classification of chronic rhinosinusitis.

Authors:  Christopher F Thompson; Caroline P E Price; Julia He Huang; Jin-Young Min; Lydia A Suh; Stephanie Shintani-Smith; David B Conley; Robert P Schleimer; Robert C Kern; Bruce K Tan
Journal:  Int Forum Allergy Rhinol       Date:  2015-12-18       Impact factor: 3.858

3.  Development of Sinonasal Outcome Test (SNOT-22) Domains in Chronic Rhinosinusitis With Nasal Polyps.

Authors:  Asif H Khan; Matthew Reaney; Isabelle Guillemin; Lauren Nelson; Shanshan Qin; Siddhesh Kamat; Leda Mannent; Nikhil Amin; Diane Whalley; Claire Hopkins
Journal:  Laryngoscope       Date:  2021-08-26       Impact factor: 2.970

Review 4.  Personalized Management of Patients with Chronic Rhinosinusitis with Nasal Polyps in Clinical Practice: A Multidisciplinary Consensus Statement.

Authors:  Eugenio De Corso; Maria Beatrice Bilò; Andrea Matucci; Veronica Seccia; Fulvio Braido; Matteo Gelardi; Enrico Heffler; Manuela Latorre; Luca Malvezzi; Girolamo Pelaia; Gianenrico Senna; Paolo Castelnuovo; Giorgio Walter Canonica
Journal:  J Pers Med       Date:  2022-05-23

5.  The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy.

Authors:  Helen Neighbour; Mena Soliman; Lisa M Steacy; Pascal Hickey; Beth Forbes; Mark Larché; Anne K Ellis
Journal:  Clin Transl Allergy       Date:  2018-04-12       Impact factor: 5.871

6.  Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis.

Authors:  Katrin König; Christine Klemens; Katharina Eder; Marion San Nicoló; Sven Becker; Matthias F Kramer; Moritz Gröger
Journal:  Allergy Asthma Clin Immunol       Date:  2015-09-22       Impact factor: 3.406

7.  Nasal mucus proteome and its involvement in allergic rhinitis.

Authors:  Peter Valentin Tomazic; Barbara Darnhofer; Ruth Birner-Gruenberger
Journal:  Expert Rev Proteomics       Date:  2020-04-08       Impact factor: 3.940

8.  Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis.

Authors:  Karin Jonstam; Brian N Swanson; Leda P Mannent; Lars-Olaf Cardell; Nian Tian; Ying Wang; Donghui Zhang; Chunpeng Fan; Gabriele Holtappels; Jennifer D Hamilton; Annette Grabher; Neil M H Graham; Gianluca Pirozzi; Claus Bachert
Journal:  Allergy       Date:  2019-01-21       Impact factor: 13.146

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.